<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><FONT STYLE="font-size: 18pt"><B>UNITED
STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
</B></FONT><B><FONT STYLE="font-size: 10pt">WASHINGTON, D.C. 20549</FONT></B><FONT STYLE="font-size: 10pt"> </FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">PURSUANT TO SECTION 13
OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">DATE OF REPORT (DATE OF
EARLIEST EVENT REPORTED):&nbsp;<B> January 25, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><FONT STYLE="font-size: 18pt"><B><U>Skinny
Nutritional Corp.<BR>
</U></B></FONT><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0">COMMISSION FILE NUMBER<B>:&nbsp;&nbsp;<U>0-51313</U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 50%; font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">Nevada</TD>
    <TD STYLE="width: 50%; font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">88-0314792</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; text-align: center">(State or other jurisdiction of incorporation or organization)</TD>
    <TD STYLE="font-size: 10pt; text-align: center">(I.R.S. Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 100%; font-size: 10pt; font-weight: bold; text-align: center">Three Bala Plaza East, Suite 101</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-decoration: underline; text-align: center">Bala Cynwyd, PA 19004</TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; text-align: center">(Address and zip code of principal executive offices)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-right: 0; margin-left: 0"><FONT STYLE="font-size: 10pt"><B><U>(610)
784-2000<BR>
</U></B>(Registrant&rsquo;s telephone number, including area code </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 100%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">CHECK THE APPROPRIATE BOX BELOW IF THE FORM
        8-K FILING IS INTENDED TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><FONT STYLE="font-family: Wingdings"><B>&uml;</B></FONT>
        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><BR>
<BR STYLE="mso-special-character: line-break">
<BR STYLE="mso-special-character: line-break">
&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 10%; vertical-align: top; font-size: 10pt; font-weight: bold">Item&nbsp;3.02</TD>
    <TD STYLE="width: 90%; padding-left: 8.8pt; font-size: 10pt; font-weight: bold">Unregistered Sales of Equity Securities.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 4.3pt">On January 25, 2012, Skinny Nutritional Corp. (the
        &ldquo;Company&rdquo;) issued an aggregate of 65,100,000 shares of the Company&rsquo;s common stock, par value $0.001 per share
        (the &ldquo;Initial Shares&rdquo;), to Ironridge Global IV, Ltd. (&ldquo;Ironridge&rdquo;), in settlement of $1,255,231.64 in accounts
        payable of the Company (the &ldquo;Accounts Payable&rdquo;). The issuance is exempt from the registration requirements of the Securities
        Act of 1933, as amended, pursuant to Section 3(a)(10) thereof, as an issuance of securities in exchange for bona fide outstanding
        claims, where the terms and conditions of such issuance are approved by a court after a hearing upon the fairness of such terms
        and conditions.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 4.3pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 4.3pt">The Initial Shares were issued pursuant to an Order
        for Approval of Stipulation for Settlement of Claims (the &ldquo;Order&rdquo;) between the Company and Ironridge, in settlement
        of the <I>bona fide</I> accounts payable of the Company, which had been purchased by Ironridge from certain creditors of the Company,
        in an amount equal to the Accounts Payable, plus fees and costs. The Order was entered by the Superior Court of the State of California,
        County of Los Angeles, Central District (Case No. BC474492) on January 23, 2012. The Order also provides for an adjustment in the
        total number of shares which may be issuable to Ironridge based on a calculation period for the transaction, defined as that number
        of consecutive trading days following the date on which the Initial Shares were issued (the &ldquo;Issuance Date&rdquo;) required
        for the aggregate trading volume of the Common Stock, as reported by Bloomberg LP, to exceed $4 million (the &ldquo;Calculation
        Period&rdquo;). Pursuant to the Order, Ironridge will retain 2,000,000 shares of the Company&rsquo;s Common Stock, plus that number
        of shares (the &ldquo;Final Amount&rdquo;) with an aggregate value equal to (a) the sum of the Accounts Payable plus $125,523 and
        reasonable attorney fees through the end of the Calculation Period, (b) divided by 80% of the following: the volume weighted average
        price (&ldquo;VWAP&rdquo;) of the Common Stock over the length of the Calculation Period, as reported by Bloomberg, not to exceed
        the arithmetic average of the individual daily VWAPs of any five trading days during the Calculation Period.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 4.3pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 4.3pt">Pursuant to the Order, for every ten million shares
        of the Company&rsquo;s Common Stock that trade during the Calculation Period, or if at any time during the Calculation Period a
        daily VWAP is below 80% of the closing price on the day before the Issuance Date, the Company will immediately issue additional
        shares (each, an &ldquo;Additional Issuance&rdquo;), subject to the limitation in the paragraph below. At the end of the Calculation
        Period, (a) if the sum of the Initial Shares and any Additional Issuance is less than the Final Amount, the Company shall immediately
        issue additional shares to Ironridge, up to the Final Amount, and (b) if the sum of the Initial Shares and any Additional Issuance
        is greater than the Final Amount, Ironridge shall promptly return any remaining shares to the Company and its transfer agent for
        cancellation.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 4.3pt">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.85pt 0 4.3pt">However, the Order provides that under no circumstances
        shall the Company issue to Ironridge a number of shares of Common Stock in connection with the settlement of claims which, when
        aggregated with all shares of Common Stock then owned or beneficially owned or controlled by Ironridge and its affiliates, at any
        one time exceed 9.99% of the total number of shares of Common Stock of the Company then issued and outstanding.</P></TD></TR>
<TR>
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding: 5pt 11.4pt 5pt 11.5pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 42%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 56%; font-weight: bold">Skinny Nutritional Corp.</TD></TR>
<TR>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>By: <U>/s/ Michael Salaman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Michael Salaman</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: &nbsp;&nbsp;Chief Executive Officer</TD></TR>
<TR>
    <TD>&nbsp;Date: &nbsp;&nbsp;January 27, 2012</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">3<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v300623_8k.htm", "secsgml_size_bytes": 14106}]
{"company-data": {"conformed-name": "Skinny Nutritional Corp.", "cik": "0001176325", "assigned-sic": "5141", "irs-number": "233100268", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51313", "film-number": "12552282"}, "business-address": {"street1": "3 BALA PLAZA EAST", "street2": "SUITE 117", "city": "BALA CYNWYD", "state": "PA", "zip": "19004", "phone": "610-784-2000"}, "mail-address": {"street1": "3 BALA PLAZA EAST", "street2": "SUITE 117", "city": "BALA CYNWYD", "state": "PA", "zip": "19004"}, "former-company": {"former-conformed-name": "CREATIVE ENTERPRISES INTERNATIONAL INC", "date-changed": "20020625"}}
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13
OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF
EARLIEST EVENT REPORTED):
January 25, 2012
Skinny
Nutritional Corp.
(Exact name of registrant as specified in its charter)
COMMISSION FILE NUMBER
:
0-51313
Nevada
88-0314792
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
Three Bala Plaza East, Suite 101
Bala Cynwyd, PA 19004
(Address and zip code of principal executive offices)
(610)
784-2000
(Registrant's telephone number, including area code
CHECK THE APPROPRIATE BOX BELOW IF THE FORM
        8-K FILING IS INTENDED TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 3.02
Unregistered Sales of Equity Securities.
On January 25, 2012, Skinny Nutritional Corp. (the
        "Company") issued an aggregate of 65,100,000 shares of the Company's common stock, par value $0.001 per share
        (the "Initial Shares"), to Ironridge Global IV, Ltd. ("Ironridge"), in settlement of $1,255,231.64 in accounts
        payable of the Company (the "Accounts Payable"). The issuance is exempt from the registration requirements of the Securities
        Act of 1933, as amended, pursuant to Section 3(a)(10) thereof, as an issuance of securities in exchange for bona fide outstanding
        claims, where the terms and conditions of such issuance are approved by a court after a hearing upon the fairness of such terms
        and conditions.
The Initial Shares were issued pursuant to an Order
        for Approval of Stipulation for Settlement of Claims (the "Order") between the Company and Ironridge, in settlement
        of the
bona fide
accounts payable of the Company, which had been purchased by Ironridge from certain creditors of the Company,
        in an amount equal to the Accounts Payable, plus fees and costs. The Order was entered by the Superior Court of the State of California,
        County of Los Angeles, Central District (Case No. BC474492) on January 23, 2012. The Order also provides for an adjustment in the
        total number of shares which may be issuable to Ironridge based on a calculation period for the transaction, defined as that number
        of consecutive trading days following the date on which the Initial Shares were issued (the "Issuance Date") required
        for the aggregate trading volume of the Common Stock, as reported by Bloomberg LP, to exceed $4 million (the "Calculation
        Period"). Pursuant to the Order, Ironridge will retain 2,000,000 shares of the Company's Common Stock, plus that number
        of shares (the "Final Amount") with an aggregate value equal to (a) the sum of the Accounts Payable plus $125,523 and
        reasonable attorney fees through the end of the Calculation Period, (b) divided by 80% of the following: the volume weighted average
        price ("VWAP") of the Common Stock over the length of the Calculation Period, as reported by Bloomberg, not to exceed
        the arithmetic average of the individual daily VWAPs of any five trading days during the Calculation Period.
Pursuant to the Order, for every ten million shares
        of the Company's Common Stock that trade during the Calculation Period, or if at any time during the Calculation Period a
        daily VWAP is below 80% of the closing price on the day before the Issuance Date, the Company will immediately issue additional
        shares (each, an "Additional Issuance"), subject to the limitation in the paragraph below. At the end of the Calculation
        Period, (a) if the sum of the Initial Shares and any Additional Issuance is less than the Final Amount, the Company shall immediately
        issue additional shares to Ironridge, up to the Final Amount, and (b) if the sum of the Initial Shares and any Additional Issuance
        is greater than the Final Amount, Ironridge shall promptly return any remaining shares to the Company and its transfer agent for
        cancellation.
However, the Order provides that under no circumstances
        shall the Company issue to Ironridge a number of shares of Common Stock in connection with the settlement of claims which, when
        aggregated with all shares of Common Stock then owned or beneficially owned or controlled by Ironridge and its affiliates, at any
        one time exceed 9.99% of the total number of shares of Common Stock of the Company then issued and outstanding.
2
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
Skinny Nutritional Corp.
By:
/s/ Michael Salaman
Name: Michael Salaman
Title:   Chief Executive Officer
Date:   January 27, 2012
3